The Deal
Tuesday, November 24, 
9:05 pm

Credit Suisse names pharma acquisition targets

Posted on September 18, 2009 at 12:29 PM
Filed under: Acquisitions | Trends
Tagged: , , , , , ,
[ Share ]  [ E-mail ]  [ Leave a Comment ]
Regarding biotech M&A, Credit Suisse Group AG (NYSE:CS) doesn't think there will be more megamergers in the next 12 to 18 months -- we could have told you that.

CS did list, however, what it sees as smaller prime acquisition targets alongside possible suitors:
  • Alexion Pharmaceuticals Inc. (NASDAQ:ALXN) by Abbott Laboratories (NYSE:ABT), Bristol-Myers Squibb Co. (NYSE:BMY) or Eli Lilly and Co. (NYSE:LLY);
  • Amylin Pharmaceuticals Inc. (NASDAQ:AMLN) by Eli Lilly;
  • Biomarin Pharmaceutical Inc.(NASDAQ:BMRN) by Abbott, Bristol-Myers Squibb or Eli Lilly;
  • Rigel Pharmaceutical Inc. (NASDAQ:RIGL) by Abbott, Bristol Myers Squibb or Johnson & Johnson (NYSE:JNJ);
  • Salix Pharmaceuticals Ltd. (NASDAQ:SLXP) by Forest Laboratories Inc. (NYSE:FRX); and
  • Vertex Pharmaceuticals Inc. (NASDAQ:VRTX) by Bristol-Myers Squibb, Gilead Sciences Inc. (NASDAQ:GILD) or Johnson & Johnson.
Credit Suisse "sees Alexion and Vertex as targets with the most merit, both of which are viewed bullishly on fundamentals and potential deals providing further upside."

A Citigroup Investment Research analyst recently upgraded Alexion to a "buy" from "hold," citing additional sales opportunities from a drug that treats a rare chronic disease called paroxysmal nocturnal hemoglobinuria, which causes a breakdown of red blood cells and leads to anemia.

See what's going on at Vertex in this istockanalyst report. - Baz Hiralal



Join Corporate Dealmaker's LinkedIn forum

Comments
Post a comment


Search


Search For

Corporate Dealmaker Video


Deal Economy 2010: IBM's Mendoza on IT services M&A

IBM's Elias Mendoza on the company's future strategic moves.
Decade of The Deal


Movers & Shakers


Juergen Lasowski
Onyx Pharmaceuticals Inc.

Edward Swallow
Northrop Grumman Corp.

Owen Mahoney
Outspark

Alice Kim
FLO TV Inc.

Eric Hausler
Isle of Capri Casinos Inc.
Juergen Lasowski, Onyx Pharmaceuticals Inc.
Edward Swallow, Northrop Grumman Corp.
Owen Mahoney, Outspark
Alice Kim, FLO TV Inc.
Eric Hausler, Isle of Capri Casinos Inc.


COMPLETE MOVERS & SHAKERS ARCHIVES

The Magazine


MACDdec1cover.gifAnd the winners are...
Even in a period when things like toxic credit default swaps and noxious structured investment vehicles dominate the conversation in many parts of the deal community, people are still willing to take the time to recognize skill and achievement in the strategic transactions that help those companies adapt and grow.
View the complete issue


Last Issue
Archives
Suggest a topic
Purchase a reprint
Subscribe to The Deal


Monthly Archives


Syndicate

Contributors

footspacer.jpg footspacer.jpg footspacer.jpg footspacer.jpg footspacer.jpg


©Copyright 2009, The Deal, LLC. All rights reserved. Please send all technical questions, comments or concerns to the Webmaster.